ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
Description and assessment of deep ligamentum flavum-preserved modified minimally invasive transforaminal lumbar interbody fusion via unilateral biportal endoscopic assistance: a one-year retrospective cohort study.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare clinical outcomes and safety of minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF), unilateral biportal endoscopic lumbar interbody fusion (ULIF), and modified MIS-TLIF via unilateral biportal endoscopic assistance (UBE-MIS-TLIF) for single-segment Schizas C/D LSS.
methodsA retrospective analysis of 205 patients (UBE-MIS-TLIF: 37, MIS-TLIF: 93, ULIF: 75) evaluated clinical outcomes using visual analogue scale (VAS), Oswestry Disability Index (ODI), Japanese Orthopaedic Association (JOA) scores, modified MacNab criteria, fusion rates, and complications over 12 months. Surgical parameters and deep ligamentum flavum (LF) preservation were also analyzed.
resultsAll groups demonstrated significant postoperative improvements in VAS [low back pain (LBP)/leg pain], ODI, and JOA scores. MIS-TLIF demonstrated higher VAS scores for incision pain compared to the other two groups. UBE-MIS-TLIF and ULIF exhibited lower LBP VAS and ODI within one week postoperatively. At final follow-up, no significant differences were observed in VAS, ODI, JOA, modified MacNab criteria, complications, intervertebral height index, or fusion rates among these groups. UBE-MIS-TLIF demonstrated significant improvements in intraoperative blood loss, wound drainage volume, CRP level, and postoperative hospital stay compared to MIS-TLIF, while showing no statistically significant differences from ULIF. However, UBE-MIS-TLIF required longer operative time and more fluoroscopy than MIS-TLIF. UBE-MIS-TLIF showed superior performance in preserving the deep LF.
conclusionUBE-MIS-TLIF, MIS-TLIF, and ULIF demonstrated comparable long-term efficacy for single-segment Schizas C/D LSS. As a modified approach, UBE-MIS-TLIF reduced invasiveness versus MIS-TLIF, achieved shorter operative time compared to ULIF, and could preserve the deep LF, offering a viable alternative for severe LSS management.
Indexed as
Identifiers
41936655What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.